TrialJournal of clinical hypertension (Greenwich, Conn.)2025

Efficacy and Safety of Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled by Amlodipine: A Phase III, Multicenter, Double-Blind, Parallel-Group, Randomized Controlled Trial.

Hongjie Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.